Latest California Healthline Stories
Of ‘Miracles’ And Money: Why Hemophilia Drugs Are So Expensive
The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn’t worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.
Use Of HIV-Prevention Drug Grows, But Lags Among Non-Whites
The pill, known as PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years — but primarily among a white demographic.
Oregon Couple’s Final Days Captured In Intimate Aid-In-Dying Video
Dr. Charles Emerick and his wife, Francie, died together last spring after both being diagnosed with terminal illnesses. First, they let their daughter turn on the camera.
Crowded Shelters And The Vicious Flu Brew Perfect Storm For The Homeless
Although homeless shelters provide lifesaving protection from the winter’s cold, they also act as incubators for diseases like influenza.
After Raising Age For Tobacco Purchases, State Sees Decreased Sales To Minors
A new study shows that, in California, moving the minimum age from 18 to 21 significantly reduced purchase by those under 18. That could be because teenagers had less access to tobacco through slightly older friends.
Jury’s In: Opioids Are Not Better Than Other Medicines For Chronic Pain
A new study followed patients with severe chronic pain for a year and found that opioids relieved pain and increased function no better than common drugs like acetaminophen and lidocaine. But the opioids carry the risk of more serious side effects, including addiction and death.
From The ER To Inpatient Care — At Home
Some health systems are encouraging selected ill emergency department patients who are stable and don’t need intensive, round-the-clock care to opt for hospital-level care at home.
How Medicaid Became A Go-To Funder For Schools
Begun as a health care safety net for children and low-income families, Medicaid increasingly underwrites a range of services in America’s public schools.
States Strive To Curb Costs For A Crucial — But Exorbitant — Hemophilia Treatment
Saving the lives of people with the bleeding disorder can require high doses of expensive blood-clotting factor. Taxpayers foot much of the bill as manufacturers profit enormously.
While Talk About Opioids Continues In DC, Addiction Treatment Is In Peril In States
The Trump administration has talked about prioritizing the opioid crisis, but states have seen little in the way of new resources. And, in some states, getting into treatment is becoming even harder.